Month: February 2019

The Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Cell Medica receives funds for its cell therapy A USD 8.7 million grant to Cell Medica has been given by Cancer Prevention and Research...

Read More

A helping hand in treatment of CRC

Business Consultant, DelveInsight's Drug Report, DelveInsight's Indication Pipeline Reports, Oncology based Indications, Pharma Consultant, Snippets

Patients suffering from Colorectal Cancer (CRC) usually gets affected with distant organ metastases spreading the tumor to other parts of...

Read More


Articles, Business Consultant, Pharma Consultant

Stem Cells therapies and CRISPR gene-editing are not new. Having able to grow the desired cells and manipulate the genome system have...

Read More

What is Cholangiocarcinoma (CCA)?

Articles, Business Consultant, DelveInsight's Indication Pipeline Reports, DelveInsight's Oncology based Reports, Pharma Consultant

Cholangiocarcinoma (BILE Duct cancer) is a type of uncommon CANCER. It arises in Bile ducts. The Bile duct is a long tubule like structure...

Read More

CRISPR proves to be a blessing for LASSA fever

Business Consultant, Gene Therapy Products, Pharma Consultant, Snippets

The ability of CRISPR to change an organism’s DNA has lead researchers, particularly from Nigeria to use the tool to perform diagnostic...

Read More


Business Consultant, Notizia, Pharma Consultant

CRISPR treatment delivers benefits in mice The researchers from Duke University along with drugmaker Sarepta Therapeutics published a...

Read More